Declared Dividend • Aug 13
Dividend of ₹1.50 announced Dividend of ₹1.50 is the same as last year. Ex-date: 1st September 2026 Payment date: 8th October 2026 Dividend yield will be 1.3%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (21% earnings payout ratio) and cash flows (36% cash payout ratio). The dividend has increased by an average of 6.5% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 77% to shift the payout ratio to a potentially unsustainable range, which is more than the 20% EPS decline seen over the last 5 years. Ankündigung • Aug 10
Rishiroop Limited, Annual General Meeting, Sep 08, 2026 Rishiroop Limited, Annual General Meeting, Sep 08, 2026, at 11:00 Indian Standard Time. Buy Or Sell Opportunity • Aug 08
Now 37% overvalued after recent price rise Over the last 90 days, the stock has risen 14% to ₹114. The fair value is estimated to be ₹83.59, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 31%. Valuation Update With 7 Day Price Move • Aug 07
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₹114, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 21x in the Chemicals industry in India. Negligible returns to shareholders over past three years. Ankündigung • Jul 23
Rishiroop Limited to Report Q1, 2027 Results on Aug 07, 2026 Rishiroop Limited announced that they will report Q1, 2027 results at 12:15 PM, Indian Standard Time on Aug 07, 2026 Reported Earnings • May 18
Full year 2026 earnings released: EPS: ₹7.31 (vs ₹11.64 in FY 2025) Full year 2026 results: EPS: ₹7.31 (down from ₹11.64 in FY 2025). Revenue: ₹760.8m (up 2.3% from FY 2025). Net income: ₹67.0m (down 37% from FY 2025). Profit margin: 8.8% (down from 14% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Ankündigung • May 02
Rishiroop Limited to Report Q4, 2026 Results on May 16, 2026 Rishiroop Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 16, 2026 Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹87.50, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 7.1% over the past three years. Reported Earnings • Feb 11
Third quarter 2026 earnings released: EPS: ₹3.74 (vs ₹2.73 loss in 3Q 2025) Third quarter 2026 results: EPS: ₹3.74 (up from ₹2.73 loss in 3Q 2025). Revenue: ₹193.1m (up 13% from 3Q 2025). Net income: ₹34.3m (up ₹59.3m from 3Q 2025). Profit margin: 18% (up from net loss in 3Q 2025). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Ankündigung • Jan 28
Rishiroop Limited to Report Q3, 2026 Results on Feb 10, 2026 Rishiroop Limited announced that they will report Q3, 2026 results on Feb 10, 2026 New Risk • Jan 14
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹900.3m (US$9.96m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 6.4% per year over the past 5 years. Market cap is less than US$10m (₹900.3m market cap, or US$9.96m). Minor Risks Dividend is not well covered by cash flows (323% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.6% net profit margin). New Risk • Nov 15
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 61% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.4% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (323% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (₹977.8m market cap, or US$11.0m). Reported Earnings • Nov 09
Second quarter 2026 earnings released: EPS: ₹0.24 (vs ₹8.06 in 2Q 2025) Second quarter 2026 results: EPS: ₹0.24 (down from ₹8.06 in 2Q 2025). Revenue: ₹169.7m (down 19% from 2Q 2025). Net income: ₹2.19m (down 97% from 2Q 2025). Profit margin: 1.3% (down from 35% in 2Q 2025). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 5% per year. Ankündigung • Oct 29
Rishiroop Limited to Report Q2, 2026 Results on Nov 08, 2025 Rishiroop Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 08, 2025 Board Change • Sep 15
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Sitendu Sharma was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Aug 25
Upcoming dividend of ₹1.50 per share Eligible shareholders must have bought the stock before 01 September 2025. Payment date: 08 October 2025. Payout ratio is a comfortable 13% but the company is paying out more than the cash it is generating. Trailing yield: 1.2%. Lower than top quartile of Indian dividend payers (1.3%). Higher than average of industry peers (0.7%). Reported Earnings • Aug 12
First quarter 2026 earnings released: EPS: ₹9.46 (vs ₹8.92 in 1Q 2025) First quarter 2026 results: EPS: ₹9.46 (up from ₹8.92 in 1Q 2025). Revenue: ₹266.7m (up 51% from 1Q 2025). Net income: ₹86.7m (up 6.1% from 1Q 2025). Profit margin: 33% (down from 46% in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Ankündigung • Aug 11
Rishiroop Limited, Annual General Meeting, Sep 08, 2025 Rishiroop Limited, Annual General Meeting, Sep 08, 2025, at 11:00 Indian Standard Time. Ankündigung • Jul 25
Rishiroop Limited to Report Q1, 2026 Results on Aug 11, 2025 Rishiroop Limited announced that they will report Q1, 2026 results on Aug 11, 2025 New Risk • May 23
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 107% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (118% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (14% net profit margin). Market cap is less than US$100m (₹1.08b market cap, or US$12.6m). Reported Earnings • May 16
Full year 2025 earnings released: EPS: ₹11.64 (vs ₹26.36 in FY 2024) Full year 2025 results: EPS: ₹11.64 (down from ₹26.36 in FY 2024). Revenue: ₹840.8m (up 9.7% from FY 2024). Net income: ₹106.6m (down 56% from FY 2024). Profit margin: 13% (down from 32% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Ankündigung • May 05
Rishiroop Limited to Report Q4, 2025 Results on May 15, 2025 Rishiroop Limited announced that they will report Q4, 2025 results on May 15, 2025 Valuation Update With 7 Day Price Move • Feb 17
Investor sentiment deteriorates as stock falls 25% After last week's 25% share price decline to ₹135, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 6.9% over the past three years. Buy Or Sell Opportunity • Feb 11
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 39% to ₹150. The fair value is estimated to be ₹192, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.4% over the last 3 years. Earnings per share has grown by 13%. Ankündigung • Jan 28
Rishiroop Limited to Report Q3, 2025 Results on Feb 10, 2025 Rishiroop Limited announced that they will report Q3, 2025 results on Feb 10, 2025 Reported Earnings • Nov 12
Second quarter 2025 earnings released: EPS: ₹8.06 (vs ₹4.91 in 2Q 2024) Second quarter 2025 results: EPS: ₹8.06 (up from ₹4.91 in 2Q 2024). Revenue: ₹280.9m (up 43% from 2Q 2024). Net income: ₹73.8m (up 64% from 2Q 2024). Profit margin: 26% (up from 23% in 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings. Ankündigung • Oct 25
Rishiroop Limited to Report Q2, 2025 Results on Nov 11, 2024 Rishiroop Limited announced that they will report Q2, 2025 results on Nov 11, 2024 Valuation Update With 7 Day Price Move • Oct 14
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₹227, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 90% over the past three years. Reported Earnings • Aug 13
First quarter 2025 earnings released: EPS: ₹8.92 (vs ₹7.36 in 1Q 2024) First quarter 2025 results: EPS: ₹8.92 (up from ₹7.36 in 1Q 2024). Revenue: ₹272.9m (up 59% from 1Q 2024). Net income: ₹81.7m (up 21% from 1Q 2024). Profit margin: 30% (down from 39% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings. Ankündigung • Aug 02
Rishiroop Limited to Report Q1, 2025 Results on Aug 12, 2024 Rishiroop Limited announced that they will report Q1, 2025 results on Aug 12, 2024 Upcoming Dividend • Jul 29
Upcoming dividend of ₹1.80 per share Eligible shareholders must have bought the stock before 05 August 2024. Payment date: 11 September 2024. Payout ratio is a comfortable 6.8% and this is well supported by cash flows. Trailing yield: 1.0%. Lower than top quartile of Indian dividend payers (1.1%). Higher than average of industry peers (0.7%). Ankündigung • Jul 16
Rishiroop Limited, Annual General Meeting, Aug 12, 2024 Rishiroop Limited, Annual General Meeting, Aug 12, 2024, at 11:00 Indian Standard Time. Valuation Update With 7 Day Price Move • Jun 04
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹154, the stock trades at a trailing P/E ratio of 5.9x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 50% over the past three years. Buy Or Sell Opportunity • Jun 04
Now 24% undervalued after recent price drop Over the last 90 days, the stock has fallen 16% to ₹154. The fair value is estimated to be ₹203, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.0% over the last 3 years. Earnings per share has declined by 34%. Reported Earnings • May 22
Full year 2024 earnings released: EPS: ₹26.36 (vs ₹8.84 in FY 2023) Full year 2024 results: EPS: ₹26.36 (up from ₹8.84 in FY 2023). Revenue: ₹984.0m (up 11% from FY 2023). Net income: ₹241.6m (up 198% from FY 2023). Profit margin: 25% (up from 9.1% in FY 2023). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has increased by 27% per year, which means it is well ahead of earnings. Ankündigung • May 10
Rishiroop Limited to Report Q4, 2024 Results on May 21, 2024 Rishiroop Limited announced that they will report Q4, 2024 results on May 21, 2024 Valuation Update With 7 Day Price Move • Feb 19
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹170, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 121% over the past three years. Reported Earnings • Feb 13
Third quarter 2024 earnings released: EPS: ₹8.39 (vs ₹2.69 in 3Q 2023) Third quarter 2024 results: EPS: ₹8.39 (up from ₹2.69 in 3Q 2023). Revenue: ₹269.9m (up 37% from 3Q 2023). Net income: ₹76.8m (up 212% from 3Q 2023). Profit margin: 28% (up from 13% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings. Reported Earnings • Nov 09
Second quarter 2024 earnings released: EPS: ₹4.91 (vs ₹6.09 in 2Q 2023) Second quarter 2024 results: EPS: ₹4.91 (down from ₹6.09 in 2Q 2023). Revenue: ₹238.5m (up 1.5% from 2Q 2023). Net income: ₹45.0m (down 19% from 2Q 2023). Profit margin: 19% (down from 24% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 40% per year, which means it is well ahead of earnings. Ankündigung • Oct 28
Rishiroop Limited to Report Q2, 2024 Results on Nov 08, 2023 Rishiroop Limited announced that they will report Q2, 2024 results on Nov 08, 2023 Upcoming Dividend • Aug 25
Upcoming dividend of ₹1.50 per share at 1.1% yield Eligible shareholders must have bought the stock before 01 September 2023. Payment date: 08 October 2023. Payout ratio is a comfortable 17% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of Indian dividend payers (1.4%). Higher than average of industry peers (0.8%). Valuation Update With 7 Day Price Move • Aug 21
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹138, the stock trades at a trailing P/E ratio of 7.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 330% over the past three years. Reported Earnings • Aug 15
First quarter 2024 earnings released: EPS: ₹7.36 (vs ₹1.29 loss in 1Q 2023) First quarter 2024 results: EPS: ₹7.36 (up from ₹1.29 loss in 1Q 2023). Revenue: ₹171.8m (down 32% from 1Q 2023). Net income: ₹67.5m (up ₹79.3m from 1Q 2023). Profit margin: 39% (up from net loss in 1Q 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 60% per year, which means it is tracking significantly ahead of earnings growth. Ankündigung • Aug 11
Rishiroop Limited, Annual General Meeting, Sep 08, 2023 Rishiroop Limited, Annual General Meeting, Sep 08, 2023, at 11:00 Indian Standard Time. Agenda: To consider Adoption of Financial Statements and Reports of the Board of Directors and the Auditors thereon; to consider Declaration of Dividend; to consider Appointment of Director; and to discuss other matters if any. New Risk • Aug 11
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (8.2% net profit margin). Market cap is less than US$100m (₹1.02b market cap, or US$12.3m). Ankündigung • Jul 29
Rishiroop Limited to Report Q1, 2024 Results on Aug 10, 2023 Rishiroop Limited announced that they will report Q1, 2024 results on Aug 10, 2023 Reported Earnings • Feb 08
Third quarter 2023 earnings released: EPS: ₹2.69 (vs ₹3.56 in 3Q 2022) Third quarter 2023 results: EPS: ₹2.69 (down from ₹3.56 in 3Q 2022). Revenue: ₹212.5m (down 9.7% from 3Q 2022). Net income: ₹24.6m (down 24% from 3Q 2022). Profit margin: 12% (down from 14% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth. Ankündigung • Jan 24
Rishiroop Limited to Report Q3, 2023 Results on Feb 07, 2023 Rishiroop Limited announced that they will report Q3, 2023 results on Feb 07, 2023 Reported Earnings • Nov 16
Second quarter 2023 earnings released: EPS: ₹6.09 (vs ₹6.39 in 2Q 2022) Second quarter 2023 results: EPS: ₹6.09 (down from ₹6.39 in 2Q 2022). Revenue: ₹279.4m (up 43% from 2Q 2022). Net income: ₹55.8m (down 10.0% from 2Q 2022). Profit margin: 20% (down from 32% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 47% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Director Atul Shah was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Ankündigung • Nov 03
Rishiroop Limited to Report Q2, 2023 Results on Nov 12, 2022 Rishiroop Limited announced that they will report Q2, 2023 results at 12:15 PM, Indian Standard Time on Nov 12, 2022 Reported Earnings • Aug 11
First quarter 2023 earnings released: ₹1.29 loss per share (vs ₹6.89 profit in 1Q 2022) First quarter 2023 results: ₹1.29 loss per share (down from ₹6.89 profit in 1Q 2022). Revenue: ₹253.1m (up 51% from 1Q 2022). Net loss: ₹11.8m (down 118% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth. Ankündigung • Jul 28
Rishiroop Limited to Report Q1, 2023 Results on Aug 09, 2022 Rishiroop Limited announced that they will report Q1, 2023 results on Aug 09, 2022 Ankündigung • Jun 25
Rishiroop Limited Declares Final Dividend for the Financial Year 2021-22 Rishiroop Limited approved declaration of final dividend on equity shares for the financial year 2021-22 at 15% i. e. INR 1.50 per equity share at its AGM held on June 24, 2022. Upcoming Dividend • Jun 09
Upcoming dividend of ₹1.50 per share Eligible shareholders must have bought the stock before 16 June 2022. Payment date: 24 July 2022. Payout ratio is a comfortable 8.4% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of Indian dividend payers (1.8%). Higher than average of industry peers (0.8%). Ankündigung • May 28
Rishiroop Limited, Annual General Meeting, Jun 24, 2022 Rishiroop Limited, Annual General Meeting, Jun 24, 2022, at 11:00 Indian Standard Time. Ankündigung • May 21
Rishiroop Limited Recommends Dividend for the Financial Year Ended March 31, 2022 Rishiroop Limited at the board of directors meeting held on May 20,2022, recommended dividend at the rate of 15% INR 1.50 per equity share of INR 10 each (subject to deduction of tax at source) for the financial year ended March 31, 2022, for the approval of the shareholders at the upcoming 37th Annual General Meeting of the Company. Reported Earnings • May 21
Full year 2022 earnings released: EPS: ₹17.78 (vs ₹30.92 in FY 2021) Full year 2022 results: EPS: ₹17.78 (down from ₹30.92 in FY 2021). Revenue: ₹935.1m (up 71% from FY 2021). Net income: ₹168.5m (down 44% from FY 2021). Profit margin: 18% (down from 55% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • May 11
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₹111, the stock trades at a trailing P/E ratio of 2.8x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 145% over the past three years. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Non-Executive Director Atul Shah was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 13
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹3.56 (down from ₹5.82 in 3Q 2021). Revenue: ₹248.8m (up 31% from 3Q 2021). Net income: ₹32.5m (down 43% from 3Q 2021). Profit margin: 13% (down from 30% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has only increased by 45% per year, which means it is significantly lagging earnings growth. Reported Earnings • Nov 01
Second quarter 2022 earnings released: EPS ₹6.39 (vs ₹2.23 in 2Q 2021) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹241.7m (up 93% from 2Q 2021). Net income: ₹62.0m (up 186% from 2Q 2021). Profit margin: 26% (up from 17% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 38% per year, which means it is significantly lagging earnings growth. Ankündigung • Aug 28
Rishiroop Limited (BSE:526492) announces an Equity Buyback for 640,000 shares, representing 6.6% for INR 80 million. Rishiroop Limited (BSE:526492) announces a share repurchase program. Under the program, the company will repurchase up to 640,000 shares, representing 6.6% of its issued share capital for INR 80 million. The shares will be repurchased at a price of INR 125 per share. The company has fixed September 9, 2021, as record date. As of August 20, 2021, the company had 9,701,288 shares in issue. Valuation Update With 7 Day Price Move • May 28
Investor sentiment deteriorated over the past week After last week's 20% share price decline to ₹87.55, the stock trades at a trailing P/E ratio of 2.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 22% over the past three years. Reported Earnings • May 23
Full year 2021 earnings released: EPS ₹30.92 (vs ₹2.93 loss in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹660.7m (up 63% from FY 2020). Net income: ₹300.0m (up ₹328.4m from FY 2020). Profit margin: 45% (up from net loss in FY 2020). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Ankündigung • May 22
Rishiroop Limited Recommends Dividend for the Year Ended March 31, 2021 Rishiroop Limited announced that at its board meeting held on May 21, 2021, the board of directors recommended dividend at 12% that is INR 1.20 per equity share of INR 10/- each (subject to deduction of tax at source) for the financial year ended March 31, 2021, for the approval of the shareholders at the upcoming 36th Annual General Meeting of the company.
Dividend, if approved by the shareholders, will be paid/dispatched within the statutory period as prescribed under Companies Act, 2013. Valuation Update With 7 Day Price Move • May 04
Investor sentiment improved over the past week After last week's 22% share price gain to ₹102, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 19x in the Chemicals industry in India. Negligible returns to shareholders over past three years. Valuation Update With 7 Day Price Move • Feb 12
Investor sentiment improved over the past week After last week's 16% share price gain to ₹92.25, the stock is trading at a trailing P/E ratio of 16.9x, up from the previous P/E ratio of 14.5x. This compares to an average P/E of 17x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 23%. Upcoming Dividend • Feb 10
Upcoming Dividend of ₹5.00 Per Share Will be paid on the 5th of March to those who are registered shareholders by the 17th of February. The trailing yield of 5.4% is in the top quartile of Indian dividend payers (1.9%), and it is higher than industry peers (0.7%). Reported Earnings • Feb 06
Third quarter 2021 earnings released: EPS ₹5.82 (vs ₹1.12 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹231.2m (up 176% from 3Q 2020). Net income: ₹56.5m (up 421% from 3Q 2020). Profit margin: 24% (up from 13% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Feb 04
New 90-day high: ₹72.00 The company is up 83% from its price of ₹39.30 on 06 November 2020. The Indian market is up 23% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period. Ankündigung • Jan 28
Rishiroop Limited to Report Q3, 2021 Results on Feb 05, 2021 Rishiroop Limited announced that they will report Q3, 2021 results on Feb 05, 2021 Valuation Update With 7 Day Price Move • Nov 25
Market bids up stock over the past week After last week's 18% share price gain to ₹59.90, the stock is trading at a trailing P/E ratio of 77.6x, up from the previous P/E ratio of 65.8x. This compares to an average P/E of 16x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 53%. Valuation Update With 7 Day Price Move • Nov 17
Market bids up stock over the past week After last week's 16% share price gain to ₹52.30, the stock is trading at a trailing P/E ratio of 67.8x, up from the previous P/E ratio of 58.4x. This compares to an average P/E of 16x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 55%. Valuation Update With 7 Day Price Move • Nov 13
Market bids up stock over the past week After last week's 25% share price gain to ₹49.25, the stock is trading at a trailing P/E ratio of 63.8x, up from the previous P/E ratio of 50.9x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 58%. Valuation Update With 7 Day Price Move • Nov 09
Market bids up stock over the past week After last week's 17% share price gain to ₹46.70, the stock is trading at a trailing P/E ratio of 60.5x, up from the previous P/E ratio of 51.8x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 53%. Reported Earnings • Nov 01
First half earnings released Over the last 12 months the company has reported total profits of ₹7.48m, down 84% from the prior year. Total revenue was ₹397.9m over the last 12 months, down 20% from the prior year. Is New 90 Day High Low • Oct 30
New 90-day high: ₹37.15 The company is up 45% from its price of ₹25.70 on 31 July 2020. The Indian market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period. Recent Insider Transactions • Oct 02
Insider recently bought ₹66k worth of stock On the 28th of September, Shradha Khanna bought around 2k shares on-market at roughly ₹32.77 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Ankündigung • Sep 13
Rishiroop Limited to Report Q1, 2021 Results on Aug 24, 2020 Rishiroop Limited announced that they will report Q1, 2021 results on Aug 24, 2020 Ankündigung • Jun 28
Rishiroop Limited to Report Q4, 2020 Results on Jun 29, 2020 Rishiroop Limited announced that they will report Q4, 2020 results on Jun 29, 2020 
